J
Jie Wang
Researcher at Nanjing Medical University
Publications - 131
Citations - 3119
Jie Wang is an academic researcher from Nanjing Medical University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 23, co-authored 94 publications receiving 2355 citations.
Papers
More filters
Journal ArticleDOI
Circular RNA has_circ_0067934 is upregulated in esophageal squamous cell carcinoma and promoted proliferation.
Wenjia Xia,Mantang Qiu,Rui Chen,Rui Chen,Siwei Wang,Xuechun Leng,Jie Wang,Youtao Xu,Jingwen Hu,Gaochao Dong,Lin Xu,Rong Yin +11 more
TL;DR: It is found that hsa_circ_0067934 was significantly overexpressed in ESCC tissues compared with paired adjacent normal tissues and the high expression level was associated with poor differentiation, which inhibited the proliferation and migration of ESCC cells and blocked cell cycle progression.
Journal ArticleDOI
PKM2 and cancer: The function of PKM2 beyond glycolysis (Review)
TL;DR: The improved understanding of PKM2 may provide a noval approach for cancer treatment, and its role as a coactivator and protein kinase, which contributes to tumorigenesis is reviewed.
Journal ArticleDOI
The Circular RNA circPRKCI Promotes Tumor Growth in Lung Adenocarcinoma.
Mantang Qiu,Mantang Qiu,Wenjia Xia,Rui Chen,Rui Chen,Siwei Wang,Youtao Xu,Zhifei Ma,W. Xu,Erbao Zhang,Jie Wang,Tian Fang,Jingwen Hu,Gaochao Dong,Rong Yin,Jun Wang,Lin Xu +16 more
TL;DR: Findings reveal high expression of the circular RNA circPRKCI drives lung adenocarcinoma tumorigenesis and may serve as a potential therapeutic target in patients with lungAdenocARCinoma.
Journal ArticleDOI
CCAT2 is a lung adenocarcinoma-specific long non-coding RNA and promotes invasion of non-small cell lung cancer
TL;DR: It is indicated that CCAT2 is a lung adenocarcinoma-specific lncRNA and promotes invasion of NSCLC and highlights its potential as a biomarker for lymph node metastasis.
Journal ArticleDOI
Circulating Tumor DNA Is Effective for the Detection of EGFR Mutation in Non–Small Cell Lung Cancer: A Meta-analysis
TL;DR: In this paper, a meta-analysis was designed to investigate the diagnostic value of ctDNA, compared with current “gold standard,” tumor tissues, and the pooled sensitivity, specificity, and diagnostic odds ratio (DOR) were calculated to evaluate the overall diagnostic performance.